{"title":"Orofacial Dystonia and Other Oromandibular Movement Disorders","authors":"N. P. Skármeta, P. Espinoza-Mellado, P. Chaná","doi":"10.5772/INTECHOPEN.78607","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.78607","url":null,"abstract":"Orofacial movement disorders (OMD) are a group of conditions that affect the motor aspect of the trigeminal, facial, and hypoglossal cranial nerves. These alterations are produced by pathologic disorders affecting the central nervous system, manifesting as isolated or combined hyperkinetic dysfunctional activities on the masticatory, facial mimic, or tongue musculatures. A comprehensive understanding of orofacial dystonias is essential to identify different variants of OMD that could be easily mislabeled or misdiagnosed. In this chapter, the authors focus on different aspects of the pathophysiology, epidemiology, clinical features, and management of orofacial dystonias and other movement disorders that are poorly recognized but not uncommon presentations of OMD, such as orofacial dyskinesias, drug-induced orofacial reactions, tardive orofacial syndromes, and bruxism.","PeriodicalId":180586,"journal":{"name":"Dystonia - Different Prospects","volume":"06 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114593732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Introductory Chapter: Dystonia - Different Prospects","authors":"T. Rizk","doi":"10.5772/INTECHOPEN.81651","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.81651","url":null,"abstract":"Dystonia is a wide-spectrum disorder which affects all age groups. Etiology of dystonia is usually diverse; in some cases within the pediatric age group, the presence of spasticity can make the diagnosis more difficult. For example, cerebral palsy patients can suffer from dystonia and spasticity, though most of pediatric cases with cerebral palsy will suffer from spasticity alone. Dystonia may result from either diffuse or localized pathology of the cerebral cortex, brain stem, or spinal cord. Management of dystonia is challenging, and specific goals should be identified. Dystonia is considered one of the most disabling conditions in pediatric age group which may remain till adulthood, treatment is usually unsatisfactory, and patients will show limited response to pharmacotherapy [1].","PeriodicalId":180586,"journal":{"name":"Dystonia - Different Prospects","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131267196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Skokou, Evangelia Eirini Tsermpini, A. Giamarelou, A. Gogos, P. Gourzis
{"title":"Tardive Dystonia due to D2 Antagonists and Other Agents","authors":"M. Skokou, Evangelia Eirini Tsermpini, A. Giamarelou, A. Gogos, P. Gourzis","doi":"10.5772/INTECHOPEN.78760","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.78760","url":null,"abstract":"Tardive dystonia due to D2 antagonists or other agents is a potentially severe extrapy- ramidal side effect emerging after long-term drug treatment, prevalent but not limited to psychiatric populations. Its course is often deteriorating, and available treatments are frequently far from satisfying. It presents with sustained muscle contractions, abnormal postures, and repetitive twisting movements and leads to increased psychiatric morbid - ity, mortality, and decline of quality of life. Inadequate clinical skill and awareness of tar dive dystonia can lead to neglect or misdiagnoses, considered as conversion symptoms or of psychogenic origin. Since the syndrome is persistent and often treatment resistant, pre vention should be a mainstay of clinical care. Emerging evidence supports positive effects of atypical antipsychotics, particularly quetiapine and clozapine. Therapies such as tet -rabenazine, valbenazine, deutetrabenazine, anticholinergics, baclofen, benzodiazepines, vitamin E, or non-pharmacologic interventions, namely botulinum toxin A, deep-brain stimulation, have been found to be helpful in some cases of tardive dystonia. This chapter comprehensively illustrates multiple aspects of this entity, including recent advances on etiology, pathophysiology, clinical presentation, epidemiology, pharmacogenomics, and treatment, aiming to enhance and deepen clinicians’ and researchers’ awareness of tar dive dystonia, with the final goal of ameliorating patients’ prognosis and quality of life. symptoms and more severe extrapyramidal symptoms (EPS) predicted nonremission of tar dive syndromes in general. Risk factors for the emergence of tardive syndromes were EPS and physical illness (stroke, diabetes mellitus, hepatitis, chronic pain, cancer, and other chronic ill -nesses, e.g., hypertension, hyperthyroidism, renal stone, gastric ulcer, hyperlipidemia, benign tumor such as ovarian tumor and uterine myoma, and heart disease), but odd ratios were not calculated specifically for TDt. No difference in risk was found comparing first- generation antipsychotics (FGAs) to SGAs.","PeriodicalId":180586,"journal":{"name":"Dystonia - Different Prospects","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122936205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Non-Motor Symptoms in Patients with Primary Dystonia","authors":"N. Semerdjieva, I. Milanov","doi":"10.5772/INTECHOPEN.78360","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.78360","url":null,"abstract":"Isolated dystonia, previously referred to as primary, is the third most common movement disorder, characterized by involuntary muscle contractions causing abnormal movements and postures with or without the presence of tremor. No matter monogenic or sporadic, the form of dystonia is a growing evidence, suggesting the presence of non-motor components to the disorder. Dystonia patients suffer from reduced quality of life, which might be related not only to the dystonic movements itself but to different non-motor symptoms and signs, as well. Based on literature review, this chapter aims to focus on the association of different types of isolated/primary dystonia (forms of focal, segmental, and generalized dystonia) with some non-motor disorders, including sleep and psychiatric disorders, cognition, as though as pain and sensory symptoms, their pathophysiological and biochemical mechanisms, relations with the symptomatic treating strategies for the abnormal movements, and specific treatment for the non-motor signs.","PeriodicalId":180586,"journal":{"name":"Dystonia - Different Prospects","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122013616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}